The series D round helped Sedgwick and NewYork-Presbyterian-backed care optimisation platform developer LeanTaas push its overall funding past the $250m mark.

The mitochondrial disease therapy developer's latest round was co-led by Novo Ventures and backed by returning investor Lundbeckfonden Ventures.

Rex Healthcare’s venture capital unit will exit the cancer diagnostics system developer, which has agreed to an acquisition by Olympus.

The CCC Marketing-backed salon operator has set a range for an initial public offering set to net it between $16.8m and $19.2m.

Tencent invested $15.3m in gene therapy-focused research services provider Obio Technology in its third funding round of 2020.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

University of Oxford joined Oxford Sciences Innovation to back neuromuscular disease therapy spinout PepGen, which will move its base to the US.

PrinterPrezz enticed the Berkeley Catalyst Fund in a series A round that will help expand its medical device 3D printing business.

Konruns Pharma came on board as Nuance closed a round that will fund the clinical progress of its small molecule anti-tumour drug candidate.

Novo returned to reinvest in the neuromuscular disorder therapy developer in a round that will fund the progress of its lead candidate through a phase 1 clinical trial.